Related Experiment Video
Updated: May 19, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Thymosin β4: a potential molecular target for tumor therapy.
Yongtao Xiao1, Yingwei Chen, Jie Wen
1Shanghai Institute of Pediatric Research, Shanghai, China.
Critical Reviews in Eukaryotic Gene Expression
|August 4, 2012
Summary
Thymosin β4 (Tβ4) is a protein involved in cell repair and migration. New research shows Tβ4 promotes tumor metastasis and angiogenesis, suggesting it as a target for cancer therapy.
Area of Science:
- Molecular biology
- Oncology
- Cell biology
Background:
- Thymosin β4 (Tβ4) is a protein implicated in actin dynamics, cellular repair, and migration.
- Emerging evidence links Tβ4 to tumor progression and angiogenesis.
Purpose of the Study:
- To investigate the role of Tβ4 in tumor metastasis and angiogenesis.
- To evaluate Tβ4 as a potential therapeutic target for cancer management.
Main Methods:
- Analysis of Tβ4 expression in metastatic tumors.
- Correlation of Tβ4 levels with vascular endothelial growth factor (VEGF) expression.
Main Results:
- Tβ4 expression is elevated in various metastatic tumors.
- Increased Tβ4 expression correlates with increased VEGF levels.
- Tβ4 facilitates tumor metastasis and angiogenesis.
Conclusions:
- Tβ4 plays a significant role in promoting tumor metastasis and angiogenesis.
- Tβ4 represents a promising therapeutic target for anti-cancer metastasis strategies.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...